AI-generated summary
The authors retrospectively reviewed medical charts of 47 patients with dry eye disease, meibomian gland dysfunction, or hyperpigmentation who received an augmented BroadBand Light treatment on the eyelids and face. They report no significant adverse effects, improved Ocular Surface Disease Index scores, and reported improvement in dry eye or blepharitis, which they describe as safe and effective. The study is retrospective and its limitations are not detailed in the abstract.
- Participants
- 47
- Who or what was studied
- Patients with meibomian gland dysfunction, dry eye disease, and/or hyperpigmentation who received BroadBand Light therapy between January 2015 and February 2020
- Limits stated in the abstract
- The study is a retrospective medical chart review, and the abstract does not report a control group or statistical limits beyond the p-values given.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Dry eye, Inflammation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.